Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stéphane Mitrovic

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Joint Bone Spine|May 23, 2017
New Markers for Adult-Onset Still's DiseaseStéphane Mitrovic, Bruno Fautrel
Expert Review of Clinical Immunology|April 17, 2018
Complications of adult-onset Still's disease and their managementStéphane Mitrovic, Bruno Fautrel
Joint Bone Spine|February 27, 2025
Systemic juvenile idiopathic arthritis and adult-onset Still's disease are the same disease and should now be designated by the same unique name, Still's diseaseStéphane Mitrovic, Bruno Fautrel
Joint Bone Spine|June 9, 2026
Club Rhumatismes et Inflammation guidelines for anti-interleukin-1 therapy: 2026 update. What's new?Stéphane Mitrovic, Bruno Fautrel
Journal of Clinical Medicine|July 2, 2021
Clinical Phenotypes of Adult-Onset Still's Disease: New Insights from Pathophysiology and Literature FindingsStéphane Mitrovic, Bruno Fautrel
Expert Review of Clinical Immunology|October 19, 2019
Reply to the Letter: 'Thrombotic microangiopathy in adult-onset Still's disease: the story is just beginning'Stéphane Mitrovic, Alexandre Hertig, Bruno Fautrel
Nature Reviews. Rheumatology|September 16, 2018
Mechanisms, biomarkers and targets for adult-onset Still's diseaseEugen Feist, Stéphane Mitrovic, Bruno Fautrel
Joint Bone Spine|February 17, 2018
Effect of biologics on fatigue in psoriatic arthritis: A systematic literature review with meta-analysisThomas Reygaerts, Stéphane Mitrovic, Bruno Fautrel, et al.
The Lancet. Rheumatology|May 16, 2025
The use of IL-1 and IL-6 inhibitors should be prioritised in Still's diseaseStéphane Mitrovic, Rashmi Sinha, Fabrizio De Benedetti, et al.
Annals of the Rheumatic Diseases|June 10, 2018
Ability of disease-modifying antirheumatic drugs to prevent or delay rheumatoid arthritis onset: a systematic literature review and meta-analysisStéphane Hilliquin, Benjamin Hugues, Stéphane Mitrovic, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Joint Bone Spine|May 23, 2017
New Markers for Adult-Onset Still's DiseaseStéphane Mitrovic, Bruno Fautrel
Expert Review of Clinical Immunology|April 17, 2018
Complications of adult-onset Still's disease and their managementStéphane Mitrovic, Bruno Fautrel
Joint Bone Spine|February 27, 2025
Systemic juvenile idiopathic arthritis and adult-onset Still's disease are the same disease and should now be designated by the same unique name, Still's diseaseStéphane Mitrovic, Bruno Fautrel
Joint Bone Spine|June 9, 2026
Club Rhumatismes et Inflammation guidelines for anti-interleukin-1 therapy: 2026 update. What's new?Stéphane Mitrovic, Bruno Fautrel
Journal of Clinical Medicine|July 2, 2021
Clinical Phenotypes of Adult-Onset Still's Disease: New Insights from Pathophysiology and Literature FindingsStéphane Mitrovic, Bruno Fautrel
Expert Review of Clinical Immunology|October 19, 2019
Reply to the Letter: 'Thrombotic microangiopathy in adult-onset Still's disease: the story is just beginning'Stéphane Mitrovic, Alexandre Hertig, Bruno Fautrel
Nature Reviews. Rheumatology|September 16, 2018
Mechanisms, biomarkers and targets for adult-onset Still's diseaseEugen Feist, Stéphane Mitrovic, Bruno Fautrel
Joint Bone Spine|February 17, 2018
Effect of biologics on fatigue in psoriatic arthritis: A systematic literature review with meta-analysisThomas Reygaerts, Stéphane Mitrovic, Bruno Fautrel, et al.
The Lancet. Rheumatology|May 16, 2025
The use of IL-1 and IL-6 inhibitors should be prioritised in Still's diseaseStéphane Mitrovic, Rashmi Sinha, Fabrizio De Benedetti, et al.
Annals of the Rheumatic Diseases|June 10, 2018
Ability of disease-modifying antirheumatic drugs to prevent or delay rheumatoid arthritis onset: a systematic literature review and meta-analysisStéphane Hilliquin, Benjamin Hugues, Stéphane Mitrovic, et al.
Pageof 4